Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis-Reference-Cited by-同舟云学术

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

Published:2012-05 Issue:5 Volume:18 Page:803-808
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Ogata Haruhiko,Kato Jun,Hirai Fumihito,Hida Nobuyuki,Matsui Toshiyuki,Matsumoto Takayuki,Koyanagi Katsuyoshi,Hibi Toshifumi

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference13 articles.

1. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)

2. Response of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506)

3. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

4. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis

5. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Systematic Review and Network Meta-analysis;Journal of Crohn's and Colitis;2024-07-09

2. Acute severe ulcerative colitis trials: the past, the present and the future;Gut;2024-06-04

3. Factors associated with changes in tacrolimus blood concentration after food initiation in patients with ulcerative colitis;PHARMAZIE;2024

4. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

5. Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis;Scientific Reports;2024-03-09